{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:43:53Z","timestamp":1790808233222,"version":"4.1.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T00:00:00Z","timestamp":1588809600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016021","name":"Corona-Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016021","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejves.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Vascular and Endovascular Surgery"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.ejvs.2020.05.001","type":"journal-article","created":{"date-parts":[[2020,7,12]],"date-time":"2020-07-12T16:01:20Z","timestamp":1594569680000},"page":"421-429","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"title":["Editor's Choice \u2013 Optimal Pharmacological Treatment of Symptomatic Peripheral Arterial Occlusive Disease and Evidence of Female Patient Disadvantage: An Analysis of Health Insurance Claims Data"],"prefix":"10.1016","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5832-8410","authenticated-orcid":false,"given":"Frederik","family":"Peters","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thea","family":"Kreutzburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik C.","family":"Rie\u00df","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska","family":"Heidemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursula","family":"Marschall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmut","family":"L'Hoest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eike S.","family":"Debus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Art","family":"Sedrakyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian-Alexander","family":"Behrendt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejvs.2020.05.001_bib1","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(13)61249-0","article-title":"Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis","volume":"382","author":"Fowkes","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.ejvs.2020.05.001_bib2","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1093\/eurheartj\/eht288","article-title":"Recent trends in morbidity and in-hospital outcomes of in-patients with peripheral arterial disease: a nationwide population-based analysis","volume":"34","author":"Malyar","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejvs.2020.05.001_bib3","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ejvs.2017.07.018","article-title":"Editor's choice - 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European society for vascular surgery (ESVS)","volume":"55","author":"Aboyans","year":"2018","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2020.05.001_bib4","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1016\/j.jacc.2016.11.007","article-title":"AHA\/ACC guideline on the management of patients with lower extremity peripheral artery disease: a report of the American college of cardiology\/American heart association task force on clinical practice guidelines","volume":"69","author":"Gerhard-Herman","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ejvs.2020.05.001_bib5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ejvs.2017.06.021","article-title":"Editor's choice - management of atherosclerotic carotid and vertebral artery disease: 2017 clinical practice guidelines of the European society for vascular surgery (ESVS)","volume":"55","author":"Naylor","year":"2018","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2020.05.001_bib6","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ejvs.2018.09.020","article-title":"Editor's choice - European society for vascular surgery (ESVS) 2019 clinical practice guidelines on the management of abdominal aorto-iliac artery aneurysms","volume":"57","author":"Wanhainen","year":"2019","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2020.05.001_bib7","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ejvs.2016.06.005","article-title":"Editor's choice - management of descending thoracic aorta diseases: clinical practice guidelines of the European society for vascular surgery (ESVS)","volume":"53","author":"Riambau","year":"2017","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2020.05.001_bib8","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials","volume":"376","author":"Baigent","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ejvs.2020.05.001_bib9","doi-asserted-by":"crossref","first-page":"e573","DOI":"10.1161\/STROKEAHA.109.556068","article-title":"Medical (nonsurgical) intervention alone is now best for prevention of stroke associated with asymptomatic severe carotid stenosis: results of a systematic review and analysis","volume":"40","author":"Abbott","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.ejvs.2020.05.001_bib10","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1001\/archneurol.2009.289","article-title":"Effects of intensive medical therapy on microemboli and cardiovascular risk in asymptomatic carotid stenosis","volume":"67","author":"Spence","year":"2010","journal-title":"Arch Neurol"},{"key":"10.1016\/j.ejvs.2020.05.001_bib11","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ejvs.2018.09.018","article-title":"Optimal antiplatelet therapy in moderate to severe asymptomatic and symptomatic carotid stenosis: a comprehensive review of the literature","volume":"57","author":"Murphy","year":"2019","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2020.05.001_bib12","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.2310\/JIM.0b013e31823548e8","article-title":"Statin therapy reduces growth of abdominal aortic aneurysms","volume":"59","author":"Karrowni","year":"2011","journal-title":"J\u00a0Investig Med"},{"key":"10.1016\/j.ejvs.2020.05.001_bib13","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1093\/eurheartj\/ehw106","volume":"37","author":"Piepoli","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejvs.2020.05.001_bib14","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1024\/0301-1526\/a000634","article-title":"Gender differences in endovascular treatment of infrainguinal peripheral artery disease","volume":"46","author":"Rie\u00df","year":"2017","journal-title":"Vasa"},{"key":"10.1016\/j.ejvs.2020.05.001_bib15","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.ejvs.2018.10.021","article-title":"Population based analysis of gender disparities in 23,715 percutaneous endovascular revascularisations in the metropolitan area of Hamburg","volume":"57","author":"Behrendt","year":"2019","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2020.05.001_bib16","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.117.005749","article-title":"Sex-based assessment of patient presentation, lesion characteristics, and treatment modalities in patients undergoing peripheral vascular intervention","volume":"11","author":"Ramkumar","year":"2018","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.ejvs.2020.05.001_bib17","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1161\/CIR.0b013e31824c39ba","article-title":"A\u00a0call to action: women and peripheral artery disease: a scientific statement from the American Heart association","volume":"125","author":"Hirsch","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.ejvs.2020.05.001_bib18","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jvs.2006.12.054","article-title":"Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with peripheral arterial disease and other high-risk conditions","volume":"45","year":"2007","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.ejvs.2020.05.001_bib19","doi-asserted-by":"crossref","first-page":"663","DOI":"10.21037\/cdt.2018.07.02","article-title":"Antiplatelet therapy for peripheral artery disease","volume":"8","author":"Melfi","year":"2018","journal-title":"Cardiovasc Diagn Ther"},{"key":"10.1016\/j.ejvs.2020.05.001_bib20","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMcp1507631","article-title":"Clinical Practice. Peripheral artery disease","volume":"374","author":"Kullo","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ejvs.2020.05.001_bib21","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1093\/eurheartj\/ehu043","article-title":"German nationwide data on current trends and management of acute myocardial infarction: discrepancies between trials and real-life","volume":"35","author":"Freisinger","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejvs.2020.05.001_bib22","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12933-017-0524-8","article-title":"Impact of diabetes on outcome in critical limb ischemia with tissue loss: a large-scaled routine data analysis","volume":"16","author":"Freisinger","year":"2017","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.ejvs.2020.05.001_bib23","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ejvs.2019.08.006","article-title":"Editor's Choice - comorbidity patterns among patients with peripheral arterial occlusive disease in Germany: a trend analysis of health insurance claims data","volume":"59","author":"Kreutzburg","year":"2020","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2020.05.001_bib24","doi-asserted-by":"crossref","first-page":"b5087","DOI":"10.1136\/bmj.b5087","article-title":"Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes","volume":"340","author":"Levesque","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.ejvs.2020.05.001_bib25","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1093\/eurheartj\/ehv006","article-title":"Peripheral arterial disease and critical limb ischaemia: still poor outcomes and lack of guideline adherence","volume":"36","author":"Reinecke","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejvs.2020.05.001_bib26","first-page":"499","article-title":"Surgical treatment of peripheral circulation disorders","volume":"21","author":"Fontaine","year":"1954","journal-title":"Helv Chir Acta"},{"key":"10.1016\/j.ejvs.2020.05.001_bib27","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00005650-199801000-00004","article-title":"Comorbidity measures for use with administrative data","volume":"36","author":"Elixhauser","year":"1998","journal-title":"Med Care"},{"key":"10.1016\/j.ejvs.2020.05.001_bib28","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.ejvs.2019.12.034","article-title":"Long term survival after femoropopliteal artery revascularisation with paclitaxel coated devices: a propensity score matched cohort analysis","volume":"59","author":"Behrendt","year":"2020","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2020.05.001_bib29","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.2517-6161.1996.tb02080.x","article-title":"Regression shrinkage and selection via the lasso","volume":"58","author":"Tibshirani","year":"1996","journal-title":"J\u00a0R Stat Soc Ser B (Methodological)"},{"key":"10.1016\/j.ejvs.2020.05.001_bib30","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jacc.2016.05.026","article-title":"Demystifying the new statistical recommendations: the use and reporting of p values","volume":"68","author":"Tijssen","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ejvs.2020.05.001_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001885","article-title":"The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement","volume":"12","author":"Benchimol","year":"2015","journal-title":"Plos Med"},{"key":"10.1016\/j.ejvs.2020.05.001_bib32","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"61","author":"von Elm","year":"2008","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.ejvs.2020.05.001_bib33","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1055\/s-0034-1396815","article-title":"Gute Praxis Sekund\u00e4rdatenanalyse (GPS): leitlinien und Empfehlungen","volume":"77","author":"Swart","year":"2015","journal-title":"Gesundheitswesen"},{"key":"10.1016\/j.ejvs.2020.05.001_bib34","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1097\/MLR.0b013e3181d991c4","article-title":"A\u00a0framework for evidence evaluation and methodological issues in implantable device studies","volume":"48","author":"Sedrakyan","year":"2010","journal-title":"Med Care"},{"key":"10.1016\/j.ejvs.2020.05.001_bib35","article-title":"A\u00a0retrospective cohort study on the provision and outcomes of pharmacological therapy after revascularization for peripheral arterial occlusive disease: a study protocol","volume":"2","author":"Peters","year":"2020","journal-title":"BMJ Surg Interv Health Tech"},{"key":"10.1016\/j.ejvs.2020.05.001_bib36","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1253\/circj.CJ-10-0077","article-title":"Long-term clinical outcome after endovascular treatment in patients with intermittent claudication due to iliofemoral artery disease","volume":"74","author":"Soga","year":"2010","journal-title":"Circ J"},{"key":"10.1016\/j.ejvs.2020.05.001_bib37","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2147\/VHRM.S15484","article-title":"ACE up the sleeve - are vascular patients medically optimized?","volume":"7","author":"Coveney","year":"2011","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.ejvs.2020.05.001_bib38","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1093\/eurheartj\/ehu080","article-title":"Statin therapy and long-term adverse limb outcomes in patients with peripheral artery disease: insights from the REACH registry","volume":"35","author":"Kumbhani","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejvs.2020.05.001_bib39","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1161\/CIRCINTERVENTIONS.113.000274","article-title":"Preoperative statins and limb salvage after lower extremity revascularization in the Medicare population","volume":"6","author":"Vogel","year":"2013","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.ejvs.2020.05.001_bib40","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s00103-019-02975-1","article-title":"Secondary prevention of coronary heart disease in women and men in Germany from 1997\u20131999 and from 2008\u20132011-Trend analysis with two national health population surveys","volume":"62","author":"Knopf","year":"2019","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"10.1016\/j.ejvs.2020.05.001_bib41","article-title":"Myocardial infarction and peripheral arterial disease: treatment patterns and long-term outcome in men and women results from a Swedish nationwide study","author":"Sigvant","year":"2019","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.ejvs.2020.05.001_bib42","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/BF03405572","article-title":"Protective vascular treatment of patients with peripheral arterial disease: guideline adherence according to year, age and gender","volume":"101","author":"Paquet","year":"2010","journal-title":"Can J Public Health"},{"key":"10.1016\/j.ejvs.2020.05.001_bib43","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1177\/1358863X11425879","article-title":"Gender differences in cholesterol-lowering medication prescribing in peripheral artery disease","volume":"16","author":"McDermott","year":"2011","journal-title":"Vasc Med"},{"key":"10.1016\/j.ejvs.2020.05.001_bib44","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s00228-015-1980-2","article-title":"Gender differences in statin prescription rates, adequacy of dosing, and association of statin therapy with outcome after heart failure hospitalization: a retrospective analysis in a community setting","volume":"72","author":"Ballo","year":"2016","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.ejvs.2020.05.001_bib45","first-page":"4","article-title":"International variation in the usage of medicines: a review of the literature","volume":"1","author":"Nolte","year":"2011","journal-title":"Rand Health Q"},{"key":"10.1016\/j.ejvs.2020.05.001_bib46","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s11606-006-5042-4","article-title":"Atherosclerotic risk factors are less intensively treated in patients with peripheral arterial disease than in patients with coronary artery disease","volume":"12","author":"McDermott","year":"1997","journal-title":"J\u00a0Gen Intern Med"},{"key":"10.1016\/j.ejvs.2020.05.001_bib47","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1177\/1060028013502000","article-title":"Association of polypharmacy and statin new-user adherence in a Veterans Health Administration population: a retrospective cohort study","volume":"47","author":"Watanabe","year":"2013","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.ejvs.2020.05.001_bib48","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s11883-016-0619-9","article-title":"Statin adherence: does gender matter?","volume":"18","author":"Goldstein","year":"2016","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.ejvs.2020.05.001_bib49","first-page":"356","article-title":"Women and peripheral arterial disease: a review of sex differences in epidemiology, clinical manifestations, and outcomes","volume":"34","author":"Srivaratharajah","year":"2018","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.ejvs.2020.05.001_bib50","series-title":"Arzneiverordnungs-Report 2017","year":"2017"},{"key":"10.1016\/j.ejvs.2020.05.001_bib51","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.ejvs.2017.03.017","article-title":"The quality of a registry based study depends on the quality of the data - without validation, it is questionable","volume":"53","author":"Venermo","year":"2017","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2020.05.001_bib52","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.ejvs.2018.06.001","article-title":"The strengths and limitations of claims based research in countries with fee for service reimbursement","volume":"56","author":"Behrendt","year":"2018","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2020.05.001_bib53","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.ejvs.2017.09.013","article-title":"Publication of vascular surgical registry data: strengths and limitations","volume":"54","author":"Bj\u00f6rck","year":"2017","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2020.05.001_bib54","first-page":"440","article-title":"Primary nonadherence to oral anticoagulants in patients with atrial fibrillation: real-world data from a population-based cohort","volume":"24","author":"Rodriguez-Bernal","year":"2018","journal-title":"J\u00a0Manag Care Spec Pharm"},{"key":"10.1016\/j.ejvs.2020.05.001_bib55","doi-asserted-by":"crossref","first-page":"721","DOI":"10.2147\/PPA.S161151","article-title":"Primary nonadherence to chronic disease medications: a meta-analysis","volume":"12","author":"Lemstra","year":"2018","journal-title":"Patient Prefer Adherence"},{"key":"10.1016\/j.ejvs.2020.05.001_bib56","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1007\/s00392-015-0905-5","article-title":"Blood pressure reductions following catheter-based renal denervation are not related to improvements in adherence to antihypertensive drugs measured by urine\/plasma toxicological analysis","volume":"104","author":"Ewen","year":"2015","journal-title":"Clin Res Cardiol"}],"container-title":["European Journal of Vascular and Endovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078588420303828?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078588420303828?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T11:53:54Z","timestamp":1761047634000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078588420303828"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":56,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S1078588420303828"],"URL":"https:\/\/doi.org\/10.1016\/j.ejvs.2020.05.001","relation":{},"ISSN":["1078-5884"],"issn-type":[{"value":"1078-5884","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Editor's Choice \u2013 Optimal Pharmacological Treatment of Symptomatic Peripheral Arterial Occlusive Disease and Evidence of Female Patient Disadvantage: An Analysis of Health Insurance Claims Data","name":"articletitle","label":"Article Title"},{"value":"European Journal of Vascular and Endovascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejvs.2020.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier B.V. on behalf of European Society for Vascular Surgery.","name":"copyright","label":"Copyright"}]}}